<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03276416</url>
  </required_header>
  <id_info>
    <org_study_id>7/2017_A</org_study_id>
    <nct_id>NCT03276416</nct_id>
  </id_info>
  <brief_title>RAPP-children, Rhinitis &amp; Asthma in Patient Perspective: Development and Validation of a Questionnaire for Quality of Life Evaluation in Children With Asthma and Allergic Rhinitis</brief_title>
  <acronym>RAPP</acronym>
  <official_title>RAPP-children, Rhinitis &amp; Asthma in Patient Perspective: Development and Validation of a Questionnaire for Quality of Life Evaluation in Children With Asthma and Allergic Rhinitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This observational study aims at developing and validating a simple questionnaire to be
      routinely applied in the clinical practice, for the evaluation of the quality of life in
      children with concomitant asthma and allergic rhinitis. The study consists of two phases:

      Phase 1: Development of the RAPP-children questionnaire starting from the validated
      RHINASTHMA-children questionnaire.

      Phase 2: Administration and validation of the RAPP-children questionnaire. 130 children with
      concomitant asthma and allergic rhinitis will be followed-up for one month. Both at baseline
      and after one month, the RAPP children and several other standardized questionnaires will be
      administered.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 10, 2018</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>RAPP-children non-response rates</measure>
    <time_frame>1 months</time_frame>
    <description>The percentage of children which do not answer the RAPP-children questions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>RAPP-children response patterns</measure>
    <time_frame>1 months</time_frame>
    <description>Frequency distributions of the responses to the RAPP-children questions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>RHINASTHMA-children response patterns</measure>
    <time_frame>1 months</time_frame>
    <description>Frequency distributions of the responses to the RHINASTHMA-children</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-ACT response patterns</measure>
    <time_frame>1 months</time_frame>
    <description>Frequency distributions of the responses to the C-ACT (Childhood Asthma Control Test)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS response pattern</measure>
    <time_frame>1 months</time_frame>
    <description>Frequency distribution of the response to the VAS (Visual Analog Scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kiddy-KINDL response patterns</measure>
    <time_frame>1 months</time_frame>
    <description>Frequency distributions of the response to the Kiddy-KINDL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary function: FEV1</measure>
    <time_frame>1 months</time_frame>
    <description>Forced expiratory volume in the first second</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary function: FVC</measure>
    <time_frame>1 months</time_frame>
    <description>Forced vital capacity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary function: FEF25-75</measure>
    <time_frame>1 months</time_frame>
    <description>Forced expiratory flow at 25-75%</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Asthma</condition>
  <condition>Allergic Rhinitis</condition>
  <arm_group>
    <arm_group_label>130 children with concomitant asthma and rhinitis</arm_group_label>
    <description>Baseline and one-month administration of RAPP-children, RHINASTHMA-children, C-ACT, VAS, Kiddy KINDLE, GRS. Baseline and one-month spirometry.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        A study population of 130 children with concomitant asthma and allergic rhinitis, aged 6 to
        11 years, both males and females, followed-up for one month at the outpatient clinic of
        Pediatric Allergology &amp; Pulmonology (PAP) within the Institute of Biomedicine and Molecular
        Immunology (IBIM) of the National Research Council (CNR) of Palermo (IBIM CNR).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 6 and 11 years

          -  Concomitant asthma and allergic rhinitis

          -  Males and Females

        Exclusion Criteria:

          -  Immunological and metabolic systemic disease

          -  Major malformations of the upper airways

          -  Active smoker
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>11 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stefania La Grutta, Ph.D.</last_name>
    <phone>0916809680</phone>
    <email>stefania.lagrutta@ibim.cnr.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Giovanni Viegi, MD</last_name>
    <phone>0916809501</phone>
    <email>giovanni.viegi@ibim.cnr.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council</name>
      <address>
        <city>Palermo</city>
        <state>Sicily</state>
        <zip>90146</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefania La Grutta, MD</last_name>
      <phone>+390916809680</phone>
      <email>stefania.lagrutta@ibim.cnr.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 5, 2017</study_first_submitted>
  <study_first_submitted_qc>September 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 8, 2017</study_first_posted>
  <last_update_submitted>March 12, 2018</last_update_submitted>
  <last_update_submitted_qc>March 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy</investigator_affiliation>
    <investigator_full_name>Stefania La Grutta, MD</investigator_full_name>
    <investigator_title>MD. Senior Researcher. Coordinator of Pediatric Allergy and Asthma Research Group. Institute of Biomedicine and Molecular Immunology, IBIM, National Research Council of Palermo, Italy.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Rhinitis, Allergic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

